Cargando…

Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study

Concurrent anxiety is frequent in major depressive disorder and a shared pathophysiological mechanism between anxiety and other depressive symptoms is plausible. The serotonin 4 receptor (5-HT(4)R) has been implicated in both depression and anxiety. This is the first study to investigate the associa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Köhler-Forsberg, Kristin, Ozenne, Brice, Larsen, Søren V., Poulsen, Asbjørn S., Landman, Elizabeth B., Dam, Vibeke H., Ip, Cheng-Teng, Jørgensen, Anders, Svarer, Claus, Knudsen, Gitte M., Frokjaer, Vibe G., Jørgensen, Martin B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276803/ https://www.ncbi.nlm.nih.gov/pubmed/35821015 http://dx.doi.org/10.1038/s41398-022-02034-5

Ejemplares similares

The Impact of Hormonal Contraceptive Use on Serotonergic Neurotransmission and Antidepressant Treatment Response: Results From the NeuroPharm 1 Study
por: Larsen, Søren Vinther, et al.
Publicado: (2022)

Evaluating cognitive disturbances as treatment target and predictor of antidepressant action in major depressive disorder: A NeuroPharm study
por: Dam, Vibeke Høyrup, et al.
Publicado: (2022)

Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study
por: Vulpius, Gunild M, et al.
Publicado: (2023)

Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression—a NeuroPharm study
por: Rasmussen, Annika Læbo, et al.
Publicado: (2023)

Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol
por: Köhler-Forsberg, Kristin, et al.
Publicado: (2020)

Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study
por: Dam, V. H., et al.
Publicado: (2021)

Generalizability of treatment outcome prediction in major depressive disorder using structural MRI: A NeuroPharm study
por: Beliveau, Vincent, et al.
Publicado: (2022)

Association between brain serotonin 4 receptor binding and reactivity to emotional faces in depressed and healthy individuals
por: Sankar, Anjali, et al.
Publicado: (2023)

Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women
por: Larsen, S. V., et al.
Publicado: (2020)

Brain serotonin transporter is associated with cognitive‐affective biases in healthy individuals
por: Armand, Sophia, et al.
Publicado: (2022)

Systemic DNA and RNA damage from oxidation after serotonergic treatment of unipolar depression
por: Jorgensen, Anders, et al.
Publicado: (2022)

Brain serotonin 4 receptor binding is inversely associated with verbal memory recall
por: Stenbæk, Dea S., et al.
Publicado: (2017)

Genetic contributions to brain serotonin transporter levels in healthy adults
por: Bruzzone, Silvia Elisabetta Portis, et al.
Publicado: (2023)

Stress-Hormone Dynamics and Working Memory in Healthy Women Who Use Oral Contraceptives Versus Non-Users
por: Høgsted, Emma Sofie, et al.
Publicado: (2021)

Association of neurocognitive function with psychiatric hospitalization and socio-demographic conditions in individuals with bipolar and major depressive disorders
por: Sankar, Anjali, et al.
Publicado: (2023)

Psychometric Properties of the Verbal Affective Memory Test-26 and Evaluation of Affective Biases in Major Depressive Disorder
por: Hjordt, Liv V., et al.
Publicado: (2020)

Deep phenotyping towards precision psychiatry of first-episode depression — the Brain Drugs-Depression cohort
por: Jensen, Kristian Høj Reveles, et al.
Publicado: (2023)

Visual stimuli induce serotonin release in occipital cortex: A simultaneous positron emission tomography/magnetic resonance imaging study
por: Hansen, Hanne Demant, et al.
Publicado: (2020)

The technology of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

Default mode network functional connectivity negatively associated with trait openness to experience
por: Marstrand-Joergensen, Maja Rou, et al.
Publicado: (2021)

BDNF val66met association with serotonin transporter binding in healthy humans
por: Fisher, P M, et al.
Publicado: (2017)

Legal problems of pharming
por: Rehbinder, Eckard, et al.
Publicado: (2009)

Common HTR2A variants and 5‐HTTLPR are not associated with human in vivo serotonin 2A receptor levels
por: Spies, Marie, et al.
Publicado: (2020)

No evidence for a role of the serotonin 4 receptor in five-factor personality traits: A positron emission tomography brain study
por: Stenbæk, Dea Siggaard, et al.
Publicado: (2017)

Identification of a Serotonin 2A Receptor Subtype of Schizophrenia Spectrum Disorders With Pimavanserin: The Sub-Sero Proof-of-Concept Trial Protocol
por: Baltzersen, Olga B., et al.
Publicado: (2020)

Neuroticism Associates with Cerebral in Vivo Serotonin Transporter Binding Differently in Males and Females
por: Tuominen, Lauri, et al.
Publicado: (2017)

Psychometric Properties and Validation of the EMOTICOM Test Battery in a Healthy Danish Population
por: Dam, Vibeke H., et al.
Publicado: (2019)

Brain Networks Implicated in Seasonal Affective Disorder: A Neuroimaging PET Study of the Serotonin Transporter
por: Nørgaard, Martin, et al.
Publicado: (2017)

Is serotonin transporter brain binding associated with the cortisol awakening response? An independent non-replication
por: Conradi, Juliane, et al.
Publicado: (2023)

Fat pharms.
por: Ma, M
Publicado: (1996)

Negative Association Between Allopregnanolone and Cerebral Serotonin Transporter Binding in Healthy Women of Fertile Age
por: Sundström Poromaa, Inger, et al.
Publicado: (2019)

The Evolution of PharmVar
por: Gaedigk, Andrea, et al.
Publicado: (2018)

PharmGED: Pharmacogenetic Effect Database
por: Zheng, C. J., et al.
Publicado: (2007)

Short-term oestrogen as a strategy to prevent postpartum depression in high-risk women: protocol for the double-blind, randomised, placebo-controlled MAMA clinical trial
por: Høgh, Stinne, et al.
Publicado: (2021)

ECOLOGY AND WILDLIFE: Pharmed Fish
por: Betts, Kellyn S.
Publicado: (2009)

Associations between the cortisol awakening response and patient-evaluated stress and mood instability in patients with bipolar disorder: an exploratory study
por: Faurholt-Jepsen, Maria, et al.
Publicado: (2021)

Pharmacogenomics Clinical Annotation Tool (PharmCAT)
por: Sangkuhl, Katrin, et al.
Publicado: (2019)

Cell Engineering and Molecular Pharming for Biopharmaceuticals
por: Abdullah, M.A, et al.
Publicado: (2008)

Introduction of APCs in J. Young Pharm.
por: Mueen, Ahmed KK
Publicado: (2012)

My Vision: J Young Pharm
por: Parasuraman, S
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_ea42tj5leq41fbc7jvncc6dpkp